Qynapse is a leader in neuroimaging analysis, providing AI-powered tools for diagnosing and prognosing central nervous system diseases. Their solutions aim to improve patient outcomes and enhance the success of clinical trials for pharmaceutical companies.
About Qynapse
Qynapse develops AI-powered software that analyzes brain images and other markers of neurodegeneration to provide accurate and reliable predictors and objective measures of CNS disorders such as Alzheimer's, Multiple Sclerosis, and Parkinson's. Their products, QyScore® and QyPredict®, are designed to assist healthcare providers, patients, and pharmaceutical companies in improving diagnosis, treatment, and clinical trial outcomes.
Clinical DocumentationPatient Engagement PlatformsData Quality PlatformsElectronic Health RecordsBusiness Intelligence PlatformsData Analysis AgentsPredictive Analytics
Media
No media yet
Screenshots and product tours appear here once the vendor claims this page.